-- U.S. RESEARCH ROUNDUP-Autodesk, NetEase, Nordstrom
-- 
-- Fri Aug 15, 2014 03:06AM EDT
-- None



Aug 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk and NetEase, on Friday.

HIGHLIGHTS * Autodesk <ADSK.O>: Pacific Crest raises target price to $66 from $60; rating outperform * Myriad Genetics <MYGN.O>: Credit Suisse cuts target price to $35 from $40; rating neutral  * NetEase <NTES.O>: Oppenheimer raises target price to $95 from $80; rating outperform   Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order. * Autodesk <ADSK.O>: Pacific Crest raises target price to $66 from $60; rating outperform * Exone Co <XONE.O>: Canaccord Genuity cuts target price to $28 from $30; rating hold  * Materialise <MTLS.O>: Piper Jaffray cuts target price to $18 from $19; rating overweight  * Myriad Genetics <MYGN.O>: Credit Suisse cuts target price to $35 from $40; rating neutral  * NetEase <NTES.O>: Oppenheimer raises target price to $95 from $80; rating outperform  * News Corp <NWSA.O>: Evercore raises target price to $19 from $18; rating equal-weight  * Nordstrom Inc <JWN.N>: Deutsche Bank cuts target price to $77 from $78; rating buy  * Piedmont Office Realty Trust <PDM.N>: RBC raises target to $20 from $18; underperform  * Vital Therapies <VTL.O>: Canaccord Genuity raises target price to $35 from $20; rating buy